AVE 0.00% 0.2¢ avecho biotechnology limited

Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 788 Posts.
    lightbulb Created with Sketch. 109
    Why is this only being done now? The trial was announced a while back and then they seek funding to conduct it - thought this would be the other way round? And $11m, seems somewhat unrealistic to me. What happens to the trial if they don't get the funding?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.